D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-1.05%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$57B
AUM Growth
-$4.5B
Cap. Flow
-$9.33B
Cap. Flow %
-16.39%
Top 10 Hldgs %
11.61%
Holding
4,472
New
311
Increased
1,300
Reduced
1,291
Closed
544

Sector Composition

1 Technology 19.32%
2 Financials 13.76%
3 Healthcare 11%
4 Consumer Discretionary 9.97%
5 Communication Services 7.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UI icon
1526
Ubiquiti
UI
$36.6B
$3.91M ﹤0.01%
13,328
-3,622
-21% -$1.06M
K icon
1527
Kellanova
K
$27.6B
$3.91M ﹤0.01%
59,758
-150,237
-72% -$9.83M
VOD icon
1528
Vodafone
VOD
$28.5B
$3.9M ﹤0.01%
344,324
+200,674
+140% +$2.27M
LXU icon
1529
LSB Industries
LXU
$576M
$3.89M ﹤0.01%
273,278
+12,825
+5% +$183K
NGC
1530
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$3.88M ﹤0.01%
395,580
CMC icon
1531
Commercial Metals
CMC
$6.47B
$3.87M ﹤0.01%
108,978
-43,211
-28% -$1.53M
ZVSA
1532
DELISTED
ZyVersa Therapeutics
ZVSA
$3.86M ﹤0.01%
1,106
FLO icon
1533
Flowers Foods
FLO
$2.9B
$3.86M ﹤0.01%
156,392
-196,941
-56% -$4.86M
AMOD
1534
Alpha Modus Holdings, Inc. Class A Common Stock
AMOD
$47.4M
$3.86M ﹤0.01%
391,519
+519
+0.1% +$5.12K
STN icon
1535
Stantec
STN
$12.6B
$3.86M ﹤0.01%
88,000
-8,200
-9% -$359K
IIII
1536
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$3.85M ﹤0.01%
386,300
REVH
1537
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$3.84M ﹤0.01%
390,687
UNFI icon
1538
United Natural Foods
UNFI
$1.77B
$3.82M ﹤0.01%
111,255
+4,330
+4% +$149K
JBLU icon
1539
JetBlue
JBLU
$1.84B
$3.82M ﹤0.01%
+575,877
New +$3.82M
KURA icon
1540
Kura Oncology
KURA
$711M
$3.82M ﹤0.01%
279,459
+188,559
+207% +$2.58M
CLVT.PRA
1541
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
$3.82M ﹤0.01%
90,000
TZPS
1542
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$3.81M ﹤0.01%
383,336
+313,500
+449% +$3.12M
TLS icon
1543
Telos
TLS
$490M
$3.81M ﹤0.01%
428,962
-180,780
-30% -$1.61M
CCRN icon
1544
Cross Country Healthcare
CCRN
$411M
$3.8M ﹤0.01%
133,900
-117,474
-47% -$3.33M
HRTX icon
1545
Heron Therapeutics
HRTX
$193M
$3.8M ﹤0.01%
899,571
-715,411
-44% -$3.02M
CDT icon
1546
CDT Equity Inc. Common Stock
CDT
$1.83M
$3.79M ﹤0.01%
250
TBCH
1547
Turtle Beach Corporation Common Stock
TBCH
$299M
$3.79M ﹤0.01%
554,953
-23,787
-4% -$162K
LIVB
1548
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
$3.78M ﹤0.01%
375,000
FACA
1549
DELISTED
Figure Acquisition Corp. I
FACA
$3.77M ﹤0.01%
383,117
+199,517
+109% +$1.97M
EPAC icon
1550
Enerpac Tool Group
EPAC
$2.3B
$3.77M ﹤0.01%
211,468
+173,976
+464% +$3.1M